Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | pyruvate kinase 1 | 0.0033 | 0.0431 | 0.1213 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0057 | 0.0979 | 0.2071 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.015 | 0.3077 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.015 | 0.3077 | 1 |
Giardia lamblia | Hypothetical protein | 0.0133 | 0.269 | 1 |
Echinococcus multilocularis | musashi | 0.0026 | 0.0278 | 0.0214 |
Trypanosoma brucei | protein kinase, putative | 0.0051 | 0.0827 | 0.253 |
Echinococcus multilocularis | pyruvate kinase | 0.0033 | 0.0431 | 0.0368 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0.0827 | 0.1498 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0033 | 0.0431 | 0.5018 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0051 | 0.0827 | 0.0767 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0203 | 0.0661 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0074 | 0.1365 | 0.4317 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0057 | 0.0979 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0057 | 0.0979 | 0.3033 |
Onchocerca volvulus | 0.0026 | 0.0278 | 0.2919 | |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0431 | 0.14 |
Loa Loa (eye worm) | pyruvate kinase | 0.0033 | 0.0431 | 0.14 |
Echinococcus multilocularis | tumor protein p63 | 0.0336 | 0.7292 | 0.7274 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0057 | 0.0979 | 0.3181 |
Leishmania major | cytochrome P450 reductase, putative | 0.0133 | 0.269 | 0.8717 |
Plasmodium vivax | ferredoxin--NADP reductase, putative | 0.0017 | 0.0065 | 0.0002 |
Schistosoma mansoni | NADH-cytochrome B5 reductase | 0.0017 | 0.0065 | 0.0002 |
Echinococcus granulosus | tumor protein p63 | 0.0336 | 0.7292 | 0.7274 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0093 | 0.1777 | 0.5776 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0051 | 0.0827 | 0.0767 |
Schistosoma mansoni | cytochrome P450 reductase | 0.015 | 0.3077 | 1 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0057 | 0.0979 | 0.3034 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0033 | 0.0431 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.015 | 0.3077 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0057 | 0.0979 | 0.3034 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0051 | 0.0827 | 0.2903 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0051 | 0.0827 | 0.253 |
Brugia malayi | Cytochrome P450 family protein | 0.0026 | 0.0269 | 0.0873 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0057 | 0.0979 | 0.3033 |
Toxoplasma gondii | ferredoxin NADP+ oxidoreductase FNR | 0.0017 | 0.0065 | 0.0004 |
Echinococcus multilocularis | methionine synthase reductase | 0.0093 | 0.1777 | 0.1723 |
Schistosoma mansoni | cytochrome B5 | 0.0017 | 0.0065 | 0.0002 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.015 | 0.3077 | 1 |
Echinococcus granulosus | lamin | 0.0026 | 0.0278 | 0.0214 |
Giardia lamblia | Flavohemoprotein lateral transfer candidate | 0.0017 | 0.0065 | 0.0002 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0456 | 1 | 1 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0057 | 0.0979 | 0.2071 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.015 | 0.3077 | 1 |
Mycobacterium ulcerans | pyruvate kinase | 0.0033 | 0.0431 | 0.1213 |
Brugia malayi | FAD binding domain containing protein | 0.0093 | 0.1777 | 0.5776 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 0.0278 | 0.0904 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0.0827 | 0.1498 |
Loa Loa (eye worm) | pyruvate kinase | 0.0033 | 0.0431 | 0.14 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0057 | 0.0979 | 0.3034 |
Loa Loa (eye worm) | hypothetical protein | 0.015 | 0.3077 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0033 | 0.0431 | 0.0368 |
Leishmania major | pyruvate kinase | 0.0033 | 0.0431 | 0.1213 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0033 | 0.0431 | 0.14 |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 0.0278 | 0.0214 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0057 | 0.0979 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.015 | 0.3077 | 1 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0057 | 0.0979 | 0.2071 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0074 | 0.1365 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0033 | 0.0431 | 0.14 |
Treponema pallidum | flavodoxin | 0.0057 | 0.0979 | 1 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0057 | 0.0979 | 0.3033 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 0.0278 | 0.0904 |
Echinococcus multilocularis | pyruvate kinase | 0.0026 | 0.0272 | 0.0209 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.015 | 0.3077 | 1 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0456 | 1 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.015 | 0.3077 | 0.3031 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.015 | 0.3077 | 0.3031 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.015 | 0.3077 | 0.3031 |
Schistosoma mansoni | lamin | 0.0026 | 0.0278 | 0.0707 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.015 | 0.3077 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.015 | 0.3077 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0051 | 0.0827 | 0.2689 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0051 | 0.0827 | 0.0767 |
Schistosoma mansoni | pyruvate kinase | 0.0033 | 0.0431 | 0.1215 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0051 | 0.0827 | 0.5863 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0051 | 0.0827 | 0.2531 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.015 | 0.3077 | 1 |
Plasmodium falciparum | ferredoxin--NADP reductase | 0.0017 | 0.0065 | 0.0002 |
Chlamydia trachomatis | pyruvate kinase | 0.0033 | 0.0431 | 0.2134 |
Onchocerca volvulus | 0.0026 | 0.0278 | 0.2919 | |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0793 | 0.2579 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.015 | 0.3077 | 0.3031 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0049 | 0.0793 | 0.2419 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0133 | 0.269 | 0.8718 |
Brugia malayi | Cytochrome b5-like Heme/Steroid binding domain containing protein | 0.0017 | 0.0065 | 0.0213 |
Schistosoma mansoni | intermediate filament proteins | 0.0026 | 0.0278 | 0.0707 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0051 | 0.0827 | 0.253 |
Brugia malayi | diaphorase | 0.0017 | 0.0065 | 0.0213 |
Plasmodium falciparum | NADH-cytochrome b5 reductase, putative | 0.0017 | 0.0065 | 0.0002 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0033 | 0.0431 | 0.1213 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.015 | 0.3077 | 1 |
Brugia malayi | flavodoxin family protein | 0.015 | 0.3077 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0051 | 0.0827 | 0.253 |
Giardia lamblia | Pyruvate kinase | 0.0033 | 0.0431 | 0.1393 |
Plasmodium falciparum | pyruvate kinase | 0.0033 | 0.0431 | 0.1215 |
Brugia malayi | intermediate filament protein | 0.0026 | 0.0278 | 0.0904 |
Plasmodium vivax | pyruvate kinase, putative | 0.0033 | 0.0431 | 0.1215 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0033 | 0.0431 | 0.1213 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0278 | 0.0904 |
Echinococcus granulosus | methionine synthase reductase | 0.0093 | 0.1777 | 0.1723 |
Onchocerca volvulus | 0.0049 | 0.0793 | 1 | |
Chlamydia trachomatis | sulfite reductase | 0.0093 | 0.1777 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0051 | 0.0827 | 0.253 |
Brugia malayi | FAD binding domain containing protein | 0.015 | 0.3077 | 1 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0456 | 1 | 1 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.015 | 0.3077 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0033 | 0.0431 | 0.1215 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.0033 | 0.0431 | 0.14 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0057 | 0.0979 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 0.0278 | 0.0214 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0051 | 0.0827 | 0.253 |
Brugia malayi | flavodoxin family protein | 0.0057 | 0.0979 | 0.3181 |
Echinococcus granulosus | pyruvate kinase | 0.0033 | 0.0431 | 0.0368 |
Leishmania major | pyruvate kinase | 0.0033 | 0.0431 | 0.1213 |
Brugia malayi | MAP kinase sur-1 | 0.0051 | 0.0827 | 0.2689 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0.0827 | 0.1498 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.015 | 0.3077 | 1 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0057 | 0.0979 | 0.3033 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0051 | 0.0827 | 0.253 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0033 | 0.0431 | 0.5018 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0051 | 0.0827 | 0.253 |
Trichomonas vaginalis | NADPH cytochrome P450, putative | 0.0057 | 0.0979 | 0.2071 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 0.0278 | 0.0904 |
Echinococcus granulosus | lamin dm0 | 0.0026 | 0.0278 | 0.0214 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0093 | 0.1777 | 0.5685 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0033 | 0.0431 | 0.2814 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0267 | 0.0868 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0051 | 0.0827 | 0.1498 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0026 | 0.0269 | 0.0873 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0074 | 0.1365 | 1 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0133 | 0.269 | 0.854 |
Loa Loa (eye worm) | diaphorase | 0.0017 | 0.0065 | 0.0213 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0051 | 0.0827 | 0.0767 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0057 | 0.0979 | 1 |
Plasmodium vivax | oxidoreductase NAD-binding domain containing protein | 0.0017 | 0.0065 | 0.0002 |
Schistosoma mansoni | lamin | 0.0026 | 0.0278 | 0.0707 |
Leishmania major | p450 reductase, putative | 0.015 | 0.3077 | 1 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0033 | 0.0431 | 0.1213 |
Echinococcus multilocularis | lamin | 0.0026 | 0.0278 | 0.0214 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0057 | 0.0979 | 0.3033 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0076 | 0.1391 | 0.4402 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0033 | 0.0431 | 0.5018 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0023 | 0.0203 | 0.0661 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0033 | 0.0431 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.015 | 0.3077 | 1 |
Loa Loa (eye worm) | cytochrome b5 reductase 4 | 0.0017 | 0.0065 | 0.0213 |
Echinococcus multilocularis | pyruvate kinase | 0.0033 | 0.0431 | 0.0368 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0133 | 0.269 | 1 |
Toxoplasma gondii | NADH-cytochrome b5 reductase 1, putative | 0.0017 | 0.0065 | 0.0004 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0057 | 0.0979 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.